Substituted quinolizine derivatives useful as HIV integrase inhibitors
US10786488B2 · kind B2 · utility
0Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2018 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Jan 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/147
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1 is as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.